Watch on Youtube



In this fascinating interview, CEO Martin Gouldstone of Oncimmune #ONC takes Vox through:



00:00. What the company does, its key USPs and how the proprietary IMMUNOinsights autoantibody profiling service helps Biopharma companies develop & monitor new drugs & precision medicines.

08:30 Current demand picture, breakeven revenue & Aug FY25 visibility.